JP2014514299A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014514299A5 JP2014514299A5 JP2014503240A JP2014503240A JP2014514299A5 JP 2014514299 A5 JP2014514299 A5 JP 2014514299A5 JP 2014503240 A JP2014503240 A JP 2014503240A JP 2014503240 A JP2014503240 A JP 2014503240A JP 2014514299 A5 JP2014514299 A5 JP 2014514299A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- hydroxy
- methylsulfonyl
- butanamide
- pyrazol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161473370P | 2011-04-08 | 2011-04-08 | |
| US61/473,370 | 2011-04-08 | ||
| PCT/IB2012/051456 WO2012137099A1 (en) | 2011-04-08 | 2012-03-27 | Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014514299A JP2014514299A (ja) | 2014-06-19 |
| JP2014514299A5 true JP2014514299A5 (enExample) | 2014-07-31 |
Family
ID=45937499
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014503240A Pending JP2014514299A (ja) | 2011-04-08 | 2012-03-27 | 抗菌剤として有用なイミダゾール、ピラゾールおよびトリアゾール誘導体 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US8809333B2 (enExample) |
| EP (1) | EP2694481B1 (enExample) |
| JP (1) | JP2014514299A (enExample) |
| KR (1) | KR20130140164A (enExample) |
| CN (1) | CN103492368A (enExample) |
| AU (1) | AU2012238379C1 (enExample) |
| CA (1) | CA2830866A1 (enExample) |
| IL (1) | IL228798A (enExample) |
| MX (1) | MX2013011432A (enExample) |
| SG (1) | SG193458A1 (enExample) |
| WO (1) | WO2012137099A1 (enExample) |
| ZA (1) | ZA201306877B (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8722686B2 (en) | 2008-09-19 | 2014-05-13 | Pfizer Inc. | Hydroxamic acid derivatives useful as antibacterial agents |
| JP5793766B2 (ja) | 2009-12-16 | 2015-10-14 | ファイザー・インク | 抗菌剤として有用なｎ−結合型ヒドロキサム酸誘導体 |
| AP3336A (en) | 2011-03-07 | 2015-07-31 | Pfizer | Fluoro-pyridinone derivatives useful as antibacterial agents |
| WO2012137099A1 (en) | 2011-04-08 | 2012-10-11 | Pfizer Inc. | Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents |
| WO2012137094A1 (en) | 2011-04-08 | 2012-10-11 | Pfizer Inc. | Isoxazole derivatives useful as antibacterial agents |
| AU2014209107B2 (en) * | 2013-01-28 | 2018-04-12 | Viamet Pharmaceuticals (NC), Inc. | Metalloenzyme inhibitor compounds |
| AR097617A1 (es) * | 2013-09-13 | 2016-04-06 | Actelion Pharmaceuticals Ltd | Derivados antibacterianos del 2h-indazol |
| KR20160098503A (ko) * | 2013-12-19 | 2016-08-18 | 액테리온 파마슈티칼 리미티드 | 항균성 1h-인다졸 및 1h-인돌 유도체 |
| AR099612A1 (es) * | 2014-03-04 | 2016-08-03 | Actelion Pharmaceuticals Ltd | Derivados antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona |
| WO2015173329A1 (en) | 2014-05-16 | 2015-11-19 | Actelion Pharmaceuticals Ltd | Antibacterial quinazoline-4(3h)-one derivatives |
| BR112017010474A2 (pt) | 2014-11-19 | 2017-12-26 | Actelion Pharmaceuticals Ltd | derivados antibacterianos de benzotiazol |
| HUE047225T2 (hu) | 2014-12-16 | 2020-04-28 | Novartis Ag | LpxC inhibitor izoxazol hidroxámsav-vegyületek |
| AR105646A1 (es) | 2015-08-11 | 2017-10-25 | Actelion Pharmaceuticals Ltd | Agentes antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituida |
| AR105848A1 (es) * | 2015-08-31 | 2017-11-15 | Actelion Pharmaceuticals Ltd | Derivados heterocíclicos antibacterianos |
| AR105889A1 (es) | 2015-09-03 | 2017-11-22 | Actelion Pharmaceuticals Ltd | Compuestos antibacterianos 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituidos |
| AU2017267194A1 (en) * | 2016-05-17 | 2019-01-17 | Idorsia Pharmaceuticals Ltd | 6-(BUTA-1,3-DIYN-1-YL)benzo[D]thiazole derivatives |
| ES2643856B1 (es) * | 2016-05-24 | 2018-08-03 | Universidad Del Pais Vasco / Euskal Herriko Unibertsitatea | Triazoles para la regulación de la homeostasis de calcio intracelular |
| SMT202000524T1 (it) | 2016-06-14 | 2020-11-10 | Novartis Ag | Forma cristallina di (r)-4-(5-(ciclopropiletinil)isossazol-3-il)-n-idrossi-2-metil-2-(metilsolfonil)butanammide come agente antibatterico |
| AU2017337946B2 (en) * | 2016-09-28 | 2020-05-07 | Dong-A St Co., Ltd. | Tetrahydropyridine derivatives and their use as antibacterial agents |
| MX2019010302A (es) | 2017-03-30 | 2019-11-21 | Hoffmann La Roche | Isoquinolinas como inhibidores de hpk1. |
| US10526343B2 (en) | 2018-03-26 | 2020-01-07 | University Of Sharjah | Heterocyclic systems and pharmaceutical applications thereof |
| JP7386841B2 (ja) | 2018-07-24 | 2023-11-27 | エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト | イソキノリン化合物及びその使用 |
| TW202024053A (zh) | 2018-10-02 | 2020-07-01 | 美商建南德克公司 | 異喹啉化合物及其用途 |
| TW202023558A (zh) | 2018-10-03 | 2020-07-01 | 美商建南德克公司 | 8-胺基異喹啉化合物及其用途 |
| DE202021105689U1 (de) | 2021-10-19 | 2021-11-11 | Punit Kumar Dwivedi | Intelligentes System zur Verbesserung des Zustands der Batterien von Elektrofahrzeugen durch maschinelles Lernen und künstliche Intelligenz |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59139388A (ja) * | 1984-01-20 | 1984-08-10 | Ajinomoto Co Inc | トリアゾ−ル−４−カルボン酸誘導体 |
| US4769461A (en) | 1986-09-16 | 1988-09-06 | American Home Products Corporation | Quinolinyl benzene hydroxamic acids as anti-inflammatory/antiallergic agents |
| US5110831A (en) | 1990-11-30 | 1992-05-05 | Du Pont Merck Pharmaceutical Company | Vinylogous hydroxamic acids and derivatives thereof as 5-lipoxygenase inhibitors |
| PL194240B1 (pl) | 1998-02-07 | 2007-05-31 | British Biotech Pharm | Zastosowanie pochodnych N-formylohydroksyloaminy i amidowa pochodna N-formylohydroksyloaminy |
| GB9925470D0 (en) | 1999-10-27 | 1999-12-29 | Smithkline Beecham Plc | Novel compounds |
| WO2002074298A1 (en) | 2001-03-21 | 2002-09-26 | Ono Pharmaceutical Co., Ltd. | Il-6 production inhibitors |
| ES2180456B1 (es) | 2001-07-20 | 2004-05-01 | Laboratorios S.A.L.V.A.T., S.A. | Isoxazoles sustituidos y su utilizacion como antibioticos. |
| JP2004196678A (ja) * | 2002-12-17 | 2004-07-15 | Dainippon Pharmaceut Co Ltd | ピラゾール系誘導体 |
| ES2387803T3 (es) | 2003-01-08 | 2012-10-02 | Novartis Vaccines And Diagnostics, Inc. | Agentes antibacterianos |
| GB0302431D0 (en) | 2003-01-30 | 2003-03-05 | Glaxo Group Ltd | Novel compounds |
| EP1828145A4 (en) | 2004-12-10 | 2009-08-19 | Univ Emory | 2'- AND 3'-SUBSTITUTED CYCLOBUTYL NUCLEOSIDE ANALOGUE FOR THE TREATMENT OF VIRAL INFECTIONS AND ANORMAL CELL PROLIFERATION |
| WO2006118155A1 (ja) | 2005-04-27 | 2006-11-09 | Ishihara Sangyo Kaisha, Ltd. | ビフェニル誘導体又はその塩、並びにそれらを有効成分として含有する農園芸用殺菌剤 |
| WO2006124897A2 (en) | 2005-05-13 | 2006-11-23 | Lexicon Genetics Incorporated | Methods and compositions for improving cognition |
| JP2009520695A (ja) | 2005-12-15 | 2009-05-28 | ヴィキュロン ファーマシューティカルズ インコーポレイテッド | 抗菌活性を有するｎ−ヒドロキシアミド誘導体 |
| WO2008045671A1 (en) | 2006-10-06 | 2008-04-17 | Janssen Pharmaceutica, N.V. | Matrix metalloprotease inhibitors |
| US7879911B2 (en) | 2007-02-01 | 2011-02-01 | Johnson Alan T | Hydroxamic acid derivatives of phenoxy-acetic acids and analogs useful as therapeutic agents for treating anthrax poisoning |
| WO2008105515A1 (ja) | 2007-02-28 | 2008-09-04 | Taisho Pharmaceutical Co., Ltd. | 新規なヒドロキサム酸誘導体 |
| WO2008115262A2 (en) | 2007-03-20 | 2008-09-25 | Curis, Inc. | Hsp90 inhibitors containing a zinc binding moiety |
| US8809695B2 (en) * | 2007-11-27 | 2014-08-19 | Nxp B.V. | Contact structure for an electronic circuit substrate and electronic circuit comprising said contact structure |
| WO2010017060A1 (en) | 2008-08-04 | 2010-02-11 | Schering Corporation | Urea derivatives as antibacterial agents |
| WO2010024356A1 (ja) | 2008-08-27 | 2010-03-04 | 大正製薬株式会社 | ナフチリジン－ｎ－オキシドを有する新規ヒドロキサム酸誘導体 |
| US8372885B2 (en) | 2008-09-17 | 2013-02-12 | Novartis Ag | Organic compounds and their uses |
| US8722686B2 (en) * | 2008-09-19 | 2014-05-13 | Pfizer Inc. | Hydroxamic acid derivatives useful as antibacterial agents |
| WO2010100475A1 (en) | 2009-03-02 | 2010-09-10 | Astrazeneca Ab | Hydroxamic acid derivatives as gram-negative antibacterial agents |
| CA2774250C (en) * | 2009-10-13 | 2013-12-17 | Pfizer Inc. | C-linked hydroxamic acid derivatives useful as antibacterial agents |
| JP5793766B2 (ja) | 2009-12-16 | 2015-10-14 | ファイザー・インク | 抗菌剤として有用なｎ−結合型ヒドロキサム酸誘導体 |
| AP3336A (en) | 2011-03-07 | 2015-07-31 | Pfizer | Fluoro-pyridinone derivatives useful as antibacterial agents |
| WO2012137094A1 (en) | 2011-04-08 | 2012-10-11 | Pfizer Inc. | Isoxazole derivatives useful as antibacterial agents |
| WO2012137099A1 (en) | 2011-04-08 | 2012-10-11 | Pfizer Inc. | Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents |
-
2012
- 2012-03-27 WO PCT/IB2012/051456 patent/WO2012137099A1/en not_active Ceased
- 2012-03-27 JP JP2014503240A patent/JP2014514299A/ja active Pending
- 2012-03-27 MX MX2013011432A patent/MX2013011432A/es not_active Application Discontinuation
- 2012-03-27 US US14/110,165 patent/US8809333B2/en not_active Expired - Fee Related
- 2012-03-27 KR KR1020137029288A patent/KR20130140164A/ko not_active Abandoned
- 2012-03-27 SG SG2013069158A patent/SG193458A1/en unknown
- 2012-03-27 AU AU2012238379A patent/AU2012238379C1/en not_active Ceased
- 2012-03-27 EP EP12713369.2A patent/EP2694481B1/en not_active Not-in-force
- 2012-03-27 CN CN201280017449.8A patent/CN103492368A/zh active Pending
- 2012-03-27 CA CA2830866A patent/CA2830866A1/en not_active Abandoned
-
2013
- 2013-09-12 ZA ZA2013/06877A patent/ZA201306877B/en unknown
- 2013-10-08 IL IL228798A patent/IL228798A/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013514345A5 (enExample) | ||
| JP2014518220A5 (enExample) | ||
| RU2012116207A (ru) | Производные индола в качестве модуляторов crac | |
| JP2014510132A5 (enExample) | ||
| AR118840A2 (es) | Combinaciones de compuestos activos que comprenden un derivado de (tio)carboxamida y un compuesto fungicida | |
| JP2022508218A5 (enExample) | ||
| JP2018535999A5 (enExample) | ||
| JP2015533157A5 (enExample) | ||
| JP2014517069A5 (enExample) | ||
| NZ609955A (en) | Sgc stimulators | |
| IL258577A (en) | 2,4-dihydroxy-nicotinamides as apj agonists | |
| JP2007531752A5 (enExample) | ||
| JP2014523880A5 (enExample) | ||
| JP2007523181A5 (enExample) | ||
| IL303196A (en) | Heteroaryl-substituted pyridines and methods of use | |
| RU2015106784A (ru) | Частично насыщенное азотсодержащее гетероциклическое соединение | |
| JP2018530591A5 (enExample) | ||
| RU2009111113A (ru) | Мидуляторы mglur5 | |
| HRP20160172T1 (hr) | Spojevi koji su inhibitori metaloenzima | |
| CA2462289A1 (en) | Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5 | |
| JP2014518219A5 (enExample) | ||
| HRP20170019T1 (hr) | Novi pirol-inhibitori od reduktaze s-nitrozoglutationa kao terapeutska sredstva | |
| JP2005511543A5 (enExample) | ||
| JP2014507464A5 (enExample) | ||
| RU2008141509A (ru) | Mglur5 модуляторы 1 |